You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Therapies and Diagnostics for Ovarian Cancer Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

Ovarian cancer (ovarian cancer) accounts for 2.4% ~ 6.5% of the common malignant tumors in women, and ranks the third among the cancers of the female reproductive system, secondary to cervical cancer and uterine body cancer.In recent years, due to the prevention and treatment of cervical cancer and uterine body cancer, some achievements have been made, while the prevention and treatment of ovarian cancer is relatively small.So ovarian cancer is the leading cause of death among cancers of the reproductive system in women.
Market Analysis and Insights: Global Therapies and Diagnostics for Ovarian Cancer Market
The global Therapies and Diagnostics for Ovarian Cancer market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Therapies and Diagnostics for Ovarian Cancer Scope and Segment
The global Therapies and Diagnostics for Ovarian Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapies and Diagnostics for Ovarian Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Surgery
Radiation Therapy
Drug Treatment
By the application, this report covers the following segments
Hospitals
Clinics
Others
Competitive Landscape:
The Therapies and Diagnostics for Ovarian Cancer key manufacturers in this market include:
Astra Zeneca
Clovis Oncology
Myriad
TESARO
AbbVie Inc
Celgene
Janssen Pharmaceuticals
Merck
Novartis AG
Quest Diagnostics Inc
1 Market Overview of Therapies and Diagnostics for Ovarian Cancer
1.1 Therapies and Diagnostics for Ovarian Cancer Market Overview
1.1.1 Therapies and Diagnostics for Ovarian Cancer Product Scope
1.1.2 Market Status and Outlook
1.2 Global Therapies and Diagnostics for Ovarian Cancer Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Therapies and Diagnostics for Ovarian Cancer Market Size by Region (2015-2026)
1.4 Global Therapies and Diagnostics for Ovarian Cancer Historic Market Size by Region (2015-2020)
1.5 Global Therapies and Diagnostics for Ovarian Cancer Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2015-2026)
1.6.1 North America Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2015-2026)
1.6.2 Europe Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2015-2026)
1.6.3 China Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2015-2026)
1.6.5 Latin America Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2015-2026)

2 Therapies and Diagnostics for Ovarian Cancer Market Overview by Type
2.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Therapies and Diagnostics for Ovarian Cancer Historic Market Size by Type (2015-2020)
2.3 Global Therapies and Diagnostics for Ovarian Cancer Forecasted Market Size by Type (2021-2026)
2.4 Surgery
2.5 Radiation Therapy
2.6 Drug Treatment

3 Therapies and Diagnostics for Ovarian Cancer Market Overview by Application
3.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Therapies and Diagnostics for Ovarian Cancer Historic Market Size by Application (2015-2020)
3.3 Global Therapies and Diagnostics for Ovarian Cancer Forecasted Market Size by Application (2021-2026)
3.4 Hospitals
3.5 Clinics
3.6 Others

4 Global Therapies and Diagnostics for Ovarian Cancer Competition Analysis by Players
4.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapies and Diagnostics for Ovarian Cancer as of 2019)
4.3 Date of Key Manufacturers Enter into Therapies and Diagnostics for Ovarian Cancer Market
4.4 Global Top Players Therapies and Diagnostics for Ovarian Cancer Headquarters and Area Served
4.5 Key Players Therapies and Diagnostics for Ovarian Cancer Product Solution and Service
4.6 Competitive Status
4.6.1 Therapies and Diagnostics for Ovarian Cancer Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Astra Zeneca
5.1.1 Astra Zeneca Profile
5.1.2 Astra Zeneca Main Business and Company’s Total Revenue
5.1.3 Astra Zeneca Products, Services and Solutions
5.1.4 Astra Zeneca Revenue (US$ Million) (2015-2020)
5.1.5 Astra Zeneca Recent Development and Reaction to Covid-19
5.2 Clovis Oncology
5.2.1 Clovis Oncology Profile
5.2.2 Clovis Oncology Main Business and Company’s Total Revenue
5.2.3 Clovis Oncology Products, Services and Solutions
5.2.4 Clovis Oncology Revenue (US$ Million) (2015-2020)
5.2.5 Clovis Oncology Recent Development and Reaction to Covid-19
5.3 Myriad
5.5.1 Myriad Profile
5.3.2 Myriad Main Business and Company’s Total Revenue
5.3.3 Myriad Products, Services and Solutions
5.3.4 Myriad Revenue (US$ Million) (2015-2020)
5.3.5 TESARO Recent Development and Reaction to Covid-19
5.4 TESARO
5.4.1 TESARO Profile
5.4.2 TESARO Main Business and Company’s Total Revenue
5.4.3 TESARO Products, Services and Solutions
5.4.4 TESARO Revenue (US$ Million) (2015-2020)
5.4.5 TESARO Recent Development and Reaction to Covid-19
5.5 AbbVie Inc
5.5.1 AbbVie Inc Profile
5.5.2 AbbVie Inc Main Business and Company’s Total Revenue
5.5.3 AbbVie Inc Products, Services and Solutions
5.5.4 AbbVie Inc Revenue (US$ Million) (2015-2020)
5.5.5 AbbVie Inc Recent Development and Reaction to Covid-19
5.6 Celgene
5.6.1 Celgene Profile
5.6.2 Celgene Main Business and Company’s Total Revenue
5.6.3 Celgene Products, Services and Solutions
5.6.4 Celgene Revenue (US$ Million) (2015-2020)
5.6.5 Celgene Recent Development and Reaction to Covid-19
5.7 Janssen Pharmaceuticals
5.7.1 Janssen Pharmaceuticals Profile
5.7.2 Janssen Pharmaceuticals Main Business and Company’s Total Revenue
5.7.3 Janssen Pharmaceuticals Products, Services and Solutions
5.7.4 Janssen Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.7.5 Janssen Pharmaceuticals Recent Development and Reaction to Covid-19
5.8 Merck
5.8.1 Merck Profile
5.8.2 Merck Main Business and Company’s Total Revenue
5.8.3 Merck Products, Services and Solutions
5.8.4 Merck Revenue (US$ Million) (2015-2020)
5.8.5 Merck Recent Development and Reaction to Covid-19
5.9 Novartis AG
5.9.1 Novartis AG Profile
5.9.2 Novartis AG Main Business and Company’s Total Revenue
5.9.3 Novartis AG Products, Services and Solutions
5.9.4 Novartis AG Revenue (US$ Million) (2015-2020)
5.9.5 Novartis AG Recent Development and Reaction to Covid-19
5.10 Quest Diagnostics Inc
5.10.1 Quest Diagnostics Inc Profile
5.10.2 Quest Diagnostics Inc Main Business and Company’s Total Revenue
5.10.3 Quest Diagnostics Inc Products, Services and Solutions
5.10.4 Quest Diagnostics Inc Revenue (US$ Million) (2015-2020)
5.10.5 Quest Diagnostics Inc Recent Development and Reaction to Covid-19

6 North America Therapies and Diagnostics for Ovarian Cancer by Players and by Application
6.1 North America Therapies and Diagnostics for Ovarian Cancer Market Size and Market Share by Players (2015-2020)
6.2 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2015-2020)

7 Europe Therapies and Diagnostics for Ovarian Cancer by Players and by Application
7.1 Europe Therapies and Diagnostics for Ovarian Cancer Market Size and Market Share by Players (2015-2020)
7.2 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2015-2020)

8 China Therapies and Diagnostics for Ovarian Cancer by Players and by Application
8.1 China Therapies and Diagnostics for Ovarian Cancer Market Size and Market Share by Players (2015-2020)
8.2 China Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2015-2020)

9 Rest of Asia Pacific Therapies and Diagnostics for Ovarian Cancer by Players and by Application
9.1 Rest of Asia Pacific Therapies and Diagnostics for Ovarian Cancer Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2015-2020)

10 Latin America Therapies and Diagnostics for Ovarian Cancer by Players and by Application
10.1 Latin America Therapies and Diagnostics for Ovarian Cancer Market Size and Market Share by Players (2015-2020)
10.2 Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2015-2020)

11 Middle East & Africa Therapies and Diagnostics for Ovarian Cancer by Players and by Application
11.1 Middle East & Africa Therapies and Diagnostics for Ovarian Cancer Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2015-2020)

12 Therapies and Diagnostics for Ovarian Cancer Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis

13 Research Finding /Conclusion

14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: Nov, 2020
  • NO OF PAGES: 125